Statistics for Boston Scientific (id:8536 BSX)

Valuation metrics

Market cap

128.21B

Enterprise value

137.21B

Trailing P/E (ttm)

71.89

Forward P/E

31.18

PEG ratio

31.18

Price/Sales (ttm)

8.06

Price/Book (mrq)

6.19

Enterprise Value/Revenue

8.62

Enterprise Value/EBITDA

33.77

Overview

Shares outstanding

1.47B

Float

1.47B

Shares short

12.91M

% Held by insiders

0.00%

% Held by institutions

0.92%

Average volume (10 days)

5.61M

Average volume (90 days)

Price summary

52-Week low

53.93

52-Week high

91.08

52-Week change

38.30%

Beta

0.80

50-Day moving average

85.26

200-Day moving average

75.91

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

November 06th, 2003

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

11.26%

Operating margin

17.06%

Operational effectiveness

Return on assets

4.90%

Return on equity

8.92%

Income statement

Revenue (ttm)

10.83

Revenue per share (ttm)

10.83

Quarterly revenue growth (yoy)

-0.07

Gross profit (ttm)

9.90B

EBITDA

4.14B

Net income to common (ttm)

1.79B

Diluted EPS (ttm)

1.21

Quarterly earnings growth (yoy)

-7.10%

Balance sheet

Total cash (mrq)

2.50B

Total cash per share (mrq)

1.70

Total debt (mrq)

11.26B

Total Debt/Equity (mrq)

53.72

Current ratio (mrq)

148.20%

Book value per share (mrq)

14.05

Cash flow

Cash flow statement

2.94B

Levered free cash flow (LFCF)

1.80B